<http://schema.org/description>
"InSite Vision Announces Top-line Results from the DOUBle Phase 3 Clinical Study for the Treatment of Moderate-to-Severe Blepharitis   AzaSite Plus and DexaSite Did Not Meet Primary Endpoint of"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/07/23/insite-vision-announces-top-line-results-from-the-/20674515/>